Back
Results - Announcements
3B Blackbio DX Ltd consolidated sales down 5.48% on year in Q2FY2026, net profit slipped by 8.37%
13-Aug-2026, 07:24
3B Blackbio DX Ltd share price gained 3.33% to Rs 1246.65. The Company's net profit eased 8.37% to Rs 8.98 crore, while revenue from operations softened by 5.48% to Rs 33.49 crore in Q2FY26 over Q1FY26. The market capitalization of Healthcare Service Provider industry group stocks on BSE stood at Rs 73454.32 crore, improving 10.78%. It has inched up 3.04% over last one week and jumped by 15.68% in last one month while the market capitalization of 3B Blackbio DX Ltd has marginally improved by 3.54% and 9.16% in the same period respectively. Profit before tax (PBT) of 3B Blackbio DX Ltd stood at Rs 13.22 crore in Q2 FY26, nosediving by 16.65% year-on-year, and declining 9.76% quarter-on-quarter. EBITDA came in at Rs 2 crore, tanking 68.35% YoY and tumbling by 243.37% sequentially. Total expenses dropped by 14.66% to Rs 26.31 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 7.85 crore, inching up 8.13% YoY, while employee benefits expense was at Rs 8.55 crore, dropping 8.65% YoY. For the TTM ended FY26, revenue from operations witnessed a strong growth of 30.15% to Rs 96.47 crore, while net profit soared by 48.57% to Rs 47.69 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 1948% to Rs 35.03 crore, and PBT surged 44.37% to Rs 64.0 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 43.36 crore in FY26, as against Rs 26.95 crore in FY25. 3B Blackbio DX Ltd nosedived by 19.97% in last one year, underperforming the benchmark BSE Sensex which has slipped by 2.83% during the same period.
3B Blackbio DX Ltd share price gained 3.33% to Rs 1246.65. The Company's net profit eased 8.37% to Rs 8.98 crore, while revenue from operations softened by 5.48% to Rs 33.49 crore in Q2FY26 over Q1FY26. The market capitalization of Healthcare Service Provider industry group stocks on BSE stood at Rs 73454.32 crore, improving 10.78%. It has inched up 3.04% over last one week and jumped by 15.68% in last one month while the market capitalization of 3B Blackbio DX Ltd has marginally improved by 3.54% and 9.16% in the same period respectively. Profit before tax (PBT) of 3B Blackbio DX Ltd stood at Rs 13.22 crore in Q2 FY26, nosediving by 16.65% year-on-year, and declining 9.76% quarter-on-quarter. EBITDA came in at Rs 2 crore, tanking 68.35% YoY and tumbling by 243.37% sequentially. Total expenses dropped by 14.66% to Rs 26.31 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 7.85 crore, inching up 8.13% YoY, while employee benefits expense was at Rs 8.55 crore, dropping 8.65% YoY. For the TTM ended FY26, revenue from operations witnessed a strong growth of 30.15% to Rs 96.47 crore, while net profit soared by 48.57% to Rs 47.69 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 1948% to Rs 35.03 crore, and PBT surged 44.37% to Rs 64.0 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 43.36 crore in FY26, as against Rs 26.95 crore in FY25. 3B Blackbio DX Ltd nosedived by 19.97% in last one year, underperforming the benchmark BSE Sensex which has slipped by 2.83% during the same period.